Ionis Pharmaceuticals Inc at Evercore ISI HealthCONx Conference Transcript
Welcome, everyone. This is Josh Schimmer from the Evercore ISI biotech team. I'm very pleased to be joined by Brett Monia, Chief Executive Officer of Ionis; and Beth Hougen, Chief Financial Officer.
Ionis' pipeline is really turning into a breathtaking journey through science. I've absolutely loved doing some of the webcast that we've done with Ionis scientists really digging into each of the programs in the pipeline and really understanding the nuts and bolts, the genetics, the biology and the commercial outlook. It really feels like Ionis is a very different Ionis this year than it was 2 or 3 years ago and 5 and 10 years ago. I know a lot of that is driven by this evolving platform.
Questions & Answers
So Brett, maybe you can just kind of give us the snapshot of how the antisense platform at Ionis has changed from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |